SCHEMBL6651736

SCHEMBL6651736

Fc1ccc(-c2ccncc2-c2nc(-c3ccc(Cl)cc3)cs2)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.61
KDM4E B2RXH2 4/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
AR P10275 2/20 0.61
LMNA P02545 2/20 0.61
CYP19A1 P11511 4/20 0.54
RPS6KA3 P51812 2/20 0.48
NPC1 O15118 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HTT P42858 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 1/20 0.44
ALOX5 P09917 1/20 0.44
EIF4E P06730 1/20 0.44
CDC25A P30304 1/20 0.44
CDC25B P30305 1/20 0.44
CDC25C P30307 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6646252 0.87 CYP19A1 (0.55) RAB9AKDM4ESMN1; SMN2ARLMNA
SCHEMBL6649581 0.86 EIF4E (0.60) RAB9AKDM4EARCYP19A1RPS6KA3
SCHEMBL6649680 0.85 KDM4E (0.62) RAB9AKDM4ESMN1; SMN2ARLMNA
SCHEMBL6649689 0.84 AR (0.57) RAB9AKDM4EARCYP19A1RPS6KA3
SCHEMBL6628622 0.82 CYP19A1 (0.59) RAB9AKDM4EARCYP19A1RPS6KA3
SCHEMBL3813712 0.82 KDM4E (0.69) RAB9AKDM4ESMN1; SMN2ARLMNA
SCHEMBL6650065 0.82 KDM4E (0.54) RAB9AKDM4ESMN1; SMN2ARLMNA
SCHEMBL11456620 0.81 KDM4E (0.73) RAB9AKDM4ESMN1; SMN2ARLMNA
SCHEMBL28495695 0.81 KDM4E (0.73) RAB9AKDM4ESMN1; SMN2ARLMNA
SCHEMBL3814593 0.80 KDM4E (0.66) RAB9AKDM4ESMN1; SMN2ARLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed